Package 50742-611-01

Brand: oxcarbazepine

Generic: oxcarbazepine
NDC Package

Package Facts

Identity

Package NDC 50742-611-01
Digits Only 5074261101
Product NDC 50742-611
Product ID 50742-611_69d2a354-3ced-494f-bda2-f3f5c4635eaa
Description

100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50742-611-01)

Marketing

Marketing Status
Marketed Since 2025-06-01
Brand oxcarbazepine
Generic oxcarbazepine
Sample Package No

Linked Drug Pages (1)

Oxcarbazepine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "69d2a354-3ced-494f-bda2-f3f5c4635eaa", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0350742611010", "0350742612017", "0350742613014"], "unii": ["VZI5B1W380"], "rxcui": ["1365653", "1365842", "1365844"], "spl_set_id": ["70798ca9-0eda-49c0-8a7c-b775b6ae3d69"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Ingenus Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50742-611-01)", "package_ndc": "50742-611-01", "marketing_start_date": "20250601"}], "brand_name": "Oxcarbazepine", "product_id": "50742-611_69d2a354-3ced-494f-bda2-f3f5c4635eaa", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "50742-611", "generic_name": "Oxcarbazepine", "labeler_name": "Ingenus Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxcarbazepine", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "150 mg/1"}], "application_number": "ANDA215796", "marketing_category": "ANDA", "marketing_start_date": "20250601", "listing_expiration_date": "20261231"}